Astria Therapeutics (ATXS) EPS (2015 - 2025)
Astria Therapeutics (ATXS) EPS from Jun 30, 2015 to Sep 30, 2025. The TTM Astria Therapeutics (ATXS) EPS is -$2.20. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Astria Therapeutics (ATXS) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +9.71% |
| 3 Years TTM | -15.88% |
| 5 Years TTM | +26.37% |
| 10 Years TTM | -3.54% |
| All Time TTM | -16.08% |
Annual EPS change of Astria Therapeutics (ATXS)
| Year | EPS | Change |
|---|---|---|
| 2025 | -$1.74 | +4.39% |
| 2024 | -$1.67 | -5.97% |
| 2023 | -$1.78 | -5.75% |
| 2022 | -$1.88 | -87.41% |
| 2021 | -$14.97 | +750.91% |
| 2020 | -$1.76 | +451.79% |
| 2019 | -$0.32 | -89.77% |
| 2018 | -$3.12 | +39.25% |
| 2017 | -$2.24 | -80.53% |
| 2016 | -$11.50 | -10.07% |
| 2015 | -$12.78 | N/A |
Comparison Astria Therapeutics (ATXS) five years EPS CAGR with competitors
Astria Therapeutics (ATXS) five years EPS CAGR is 26.37%.